Literature DB >> 3105557

Endoscopic laser surgery. An alternative in laryngeal cancer treatment.

W F McGuirt, J A Koufman.   

Abstract

Thirty-three patients with newly diagnosed laryngeal carcinoma underwent endoscopic treatment with the carbon dioxide laser under microscopic control and venturi jet ventilation. Ten of these patients underwent emergency tumor debulking to relieve airway obstruction and to avoid emergency tracheotomy for airway control, and 23 had definitive treatment of superficial or frankly invasive carcinoma. Among the first group, all had an adequate airway after tumor debulking and could be treated with elective laryngectomy with or without radical neck dissection once their metabolic conditions had improved and they had been appropriately evaluated. Among the second group, two died of lung carcinoma but were free of laryngeal disease and two were lost to follow-up at one year. With a minimal three-year follow-up, six of the remaining 19 patients underwent additional laser procedures. None have required external laryngeal surgery or radiation therapy. Endoscopic laser therapy appears preferable to a more radical approach for carcinoma in situ, microinvasive carcinoma, or superficially invasive carcinoma of the larynx.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105557     DOI: 10.1001/archotol.1987.01860050047012

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  2 in total

1.  Risk of lymph node metastases after en bloc cold steel, en bloc laser-, and piecemeal laser surgical resection of auricular VX2 carcinoma.

Authors:  Susanne Wiegand; Christian Wiemers; Tobias Murthum; Annette P Zimmermann; Michael Bette; Robert Mandic; Jochen A Werner
Journal:  Lasers Med Sci       Date:  2012-10-03       Impact factor: 3.161

2.  Endoscopic airway management of acute upper airway obstruction.

Authors:  N Choudhury; V Perkins; I Amer; R Bhagrath; K Ghufoor
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-09       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.